Residual Neuromuscular Blockade in Cardiac Surgery Patients
Latest Information Update: 18 Feb 2022
At a glance
- Drugs Glycopyrrolate/neostigmine (Primary) ; Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
Most Recent Events
- 01 Feb 2022 Planned End Date changed from 30 Mar 2019 to 30 Aug 2018.
- 01 Feb 2022 Planned primary completion date changed from 30 Dec 2018 to 30 Aug 2018.
- 01 Feb 2022 Status changed from not yet recruiting to withdrawn prior to enrolment due to inadequate funding.